|
MEX3D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.09390000017029E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.842600E-04 |
| Normal-vs-Stage2 |
3.931000E-01 |
| Normal-vs-Stage3 |
2.623600E-03 |
| Normal-vs-Stage4 |
1.064650E-01 |
| Stage1-vs-Stage2 |
2.202600E-01 |
| Stage1-vs-Stage3 |
7.050400E-02 |
| Stage1-vs-Stage4 |
6.008400E-01 |
| Stage2-vs-Stage3 |
1.905940E-02 |
| Stage2-vs-Stage4 |
2.201800E-01 |
| Stage3-vs-Stage4 |
4.271600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.8563000004952E-07 |
| Normal-vs-AfricanAmerican |
8.523700E-03 |
| Normal-vs-Asian |
3.209200E-01 |
| Caucasian-vs-AfricanAmerican |
5.243900E-02 |
| Caucasian-vs-Asian |
4.264200E-01 |
| AfricanAmerican-vs-Asian |
6.958000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.62520000000144E-05 |
| Normal-vs-Female |
2.11279999999814E-05 |
| Male-vs-Female |
6.004100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.077300E-03 |
| Normal-vs-Extreme_Weight |
7.047600E-04 |
| Normal-vs-Obese |
8.4572000000005E-05 |
| Normal-vs-Extreme_Obese |
1.565170E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.393000E-01 |
| Normal_Weight-vs-Obese |
5.132300E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.279000E-01 |
| Extreme_Weight-vs-Obese |
1.057570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.410800E-01 |
| Obese-vs-Extreme_Obese |
1.410040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.380800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.18940000004564E-06 |
| Normal-vs-Age(61-80Yrs) |
1.161450E-03 |
| Normal-vs-Age(81-100Yrs) |
5.393800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.461700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.155380E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.939700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.365700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.940000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.88270000279456E-08 |
| Normal-VS-Type2 PRCC |
5.220200E-01 |
| Normal-VS-KIRP CIMP |
3.744200E-03 |
| Normal-VS-Unclassified PRCC |
6.664500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.78809999999974E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.436300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.039800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.839400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.355840E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.956250E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.159600E-02 |
| Normal-vs-N1 |
6.006200E-04 |
| Normal-vs-N2 |
1.381930E-03 |
| N0-vs-N1 |
3.679800E-03 |
| N0-vs-N2 |
1.157820E-01 |
| N1-vs-N2 |
5.196200E-01 |
|
|
